Cedarburg acquires Hauser Pharma

Cedarburg Pharmacetuicals, a privately-owned chemistry-based contract development manufacturing organization specializing in the production of  active pharmaceutical ingredients and key intermediates for the drug and  biopharmaceutical industries, has acquired fellow USA-based InB: Hauser  Pharmaceutical Services. The purchase further strengthens Cedarburg's  position as a leader in the apidly-rowing CDMO market and will offer  clients a more fully-integrated manufacturing platform strategically  focused on helping client's move New Chemical Entities to market, the  firm claims.

Hauser's expertise in natural products, isolation/purification and  current Good Manufacturing Practice production augment Cedarburg's  synthetic chemistry and cGMP expertise, and effectively broadens the  overall service capabilities offered to clients. The newly-formed  company, called Cedarburg Hauser Pharmaceuticals, will offer customers a  broad range of best-in-class pharmaceutical services to meet the  development and production needs of its clients, the firm claims